ARTICLE | Clinical News
VT-1129 regulatory update
September 21, 2015 7:00 AM UTC
FDA granted Qualified Infectious Disease Product (QIDP) designation to VT-1129 from Viamet to treat cryptococcal meningitis. Viamet plans to start Phase I testing of the product next quarter. VT-1129 ...